NGNE

NASDAQStock

Neurogene Inc.

$21.00-1.30 (-5.83%)

52-Week Range

$7.34

$34.37

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.69

Volume

194.4K

Avg Volume

276.9K

Performance

+31.18%

+10.07%

+27.79%

YTD

+10.62%

+33.53%

+47.68%

Price Chart

ETF Exposure

NGNE is held by 53 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
BBC	Virtus Biotech Clinical Trials ETF	0.82%	13,801	$308K	$39.0M	0.65%
IBRN	iShares Neuroscience and Healthcare ETF	0.40%	856	$20K	$4.7M	0.47%
SBIO	ALPS Medical Breakthroughs ETF	0.23%	13,806	$308K	$133.4M	0.50%
HELX	Franklin Genomic Advancements ETF	0.20%	1,840	$42K	$21.7M	0.50%
DBPG.DE	Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C	0.12%	26,522	$514K	$421.9M	0.60%
XS2D.L	Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C	0.12%	26,522	$591K	$485.5M	0.60%
KOMP	State Street SPDR S&P Kensho New Economies Composite ETF	0.09%	101,725	$2.3M	$2.48B	0.20%
VFMO	Vanguard U.S. Momentum Factor ETF	0.06%	35,495	$731K	$1.30B	0.13%
IWC	iShares Micro-Cap ETF	0.05%	26,134	$602K	$1.27B	0.60%
FESM	FIDELITY ENHANCED SMALL CAP ETF	0.04%	74,900	$1.7M	$4.11B	0.28%
SBIO.L	Invesco NASDAQ Biotech UCITS ETF	0.03%	0	$0	$416.2M	0.40%
IBB	iShares Biotechnology ETF	0.03%	96,262	$2.2M	$8.50B	0.44%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.03%	848	$20K	$72.1M	0.19%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.02%	695	$15K	$86.8M	1.19%
AVSC	Avantis U.S. Small Cap Equity ETF	0.02%	17,531	$391K	$2.36B	0.25%
IWN	iShares Russell 2000 Value ETF	0.01%	82,104	$1.9M	$12.21B	0.24%
XRS2.DE	Xtrackers Russell 2000 UCITS ETF 1C	0.01%	14,921	$289K	$2.11B	0.30%
XRSU.L	Xtrackers Russell 2000 UCITS ETF 1C	0.01%	14,921	$333K	$2.43B	0.30%
VTWV	Vanguard Russell 2000 Value ETF	0.01%	6,837	$121K	$1.00B	0.06%
XWD1.F	Xtrackers MSCI World Swap UCITS ETF	0.01%	57,917	$1.1M	$2.17B	0.19%
XWD1.SG	Xtrackers MSCI World Swap UCITS ETF	0.01%	57,917	$1.1M	$9.68B	0.00%
XWEH.DE	Xtrackers MSCI World Swap UCITS ETF 4C EUR Hedged	0.01%	57,917	$1.1M	$9.60B	0.39%
RESM	Columbia Research Enhanced Small Cap ETF	0.01%	12	$276	$3.1M	0.32%
SC0K.DE	Invesco Russell 2000 UCITS ETF	0.01%	0	$0	$189.7M	0.45%
IWM	iShares Russell 2000 ETF	0.01%	227,505	$5.2M	$69.44B	0.19%
XSU.TO	iShares U.S. Small Cap Index ETF (CAD-Hedged)	0.01%	227,505	$51K	$677.7M	0.36%
RSSL	Global X - Russell 2000 ETF	0.01%	4,519	$84K	$1.33B	0.08%
VTWO	Vanguard Russell 2000 ETF	0.01%	46,872	$828K	$14.50B	0.06%
R2SC.L	State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)	0.01%	15,355	$198K	$3.73B	0.30%
UWM	ProShares - Ultra Russell2000	0.01%	585	$13K	$264.2M	1.07%
URTY	ProShares - UltraPro Russell2000	0.00%	593	$13K	$284.9M	1.08%
SMMD	iShares Russell 2500 ETF	0.00%	3,413	$79K	$2.28B	0.23%
VXF	Vanguard Extended Market ETF	0.00%	115,861	$2.0M	$84.10B	0.05%
DFAS	Dimensional - US Small Cap ETF	0.00%	8,413	$188K	$12.65B	0.26%
HDG	ProShares - Hedge Replication ETF	0.00%	11	$245	$23.2M	0.95%
IWV	iShares Russell 3000 ETF	0.00%	4,411	$102K	$17.30B	0.20%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	2,066	$46K	$40.55B	0.17%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	1	$18	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	3	$60	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	4	$103	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	5	$119	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	6	$141	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	5	$117	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	3	$77	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	3	$58	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	1	$26	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	23	$449	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	844	$16K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	4	$77	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	722	$13K	$5.50B	0.06%

Page 1 of 2Next

About NGNE ETF Exposure

Neurogene Inc. (NGNE) is held by 53 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $21.00. Investors can gain exposure to NGNE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NGNE, sorted by portfolio weight.